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Introduction
Cancer is a genetic disease, and carcinogenesis is the process of 
acquisition of the numerous genetic and epigenetic alterations 
that encode malignant phenotypes.1,2 Melanoma is much like 
other solid organ malignancies, with many mutations and chro-
mosomal aberrations that activate proto-oncogenes and inacti-
vate tumor suppressors.3-5 Common mutations in melanoma 
include an activating mutation in BRAF codon 600 (V600E) and 
deletion of the CDKN2A locus that encodes two tumor suppres-
sors, p16INK4A and p19ARF.4,6,7 Although mutation of TP53 
is uncommon in melanoma, being seen in 10–25% of primary 
lesions,4 inactivation of the p53 signaling pathway is common 
in melanoma cell lines, with 66% displaying a significant defect 
As DNA damage checkpoints are barriers to carcinogenesis, G2 checkpoint function was quantified to test for override 
of this checkpoint during melanomagenesis. primary melanocytes displayed an effective G2 checkpoint response to 
ionizing radiation (IR)-induced DNA damage. thirty-seven percent of melanoma cell lines displayed a significant defect in 
G2 checkpoint function. Checkpoint function was melanoma subtype-specific with “epithelial-like” melanoma lines, with 
wild type NRAS and BRAF displaying an effective checkpoint, while lines with mutant NRAS and BRAF displayed defective 
checkpoint function. expression of oncogenic B-Raf in a checkpoint-effective melanoma attenuated G2 checkpoint 
function significantly but modestly. other alterations must be needed to produce the severe attenuation of G2 checkpoint 
function seen in some BRAF-mutant melanoma lines. Quantitative trait analysis tools identified mRNA species whose 
expression was correlated with G2 checkpoint function in the melanoma lines. A 165 gene signature was identified with 
a high correlation with checkpoint function (p < 0.004) and low false discovery rate (≤ 0.077). the G2 checkpoint gene 
signature predicted G2 checkpoint function with 77–94% accuracy. the signature was enriched in lysosomal genes and 
contained numerous genes that are associated with regulation of chromatin structure and cell cycle progression. the 
core machinery of the cell cycle was not altered in checkpoint-defective lines but rather numerous mediators of core 
machinery function were. When applied to an independent series of primary melanomas, the predictive G2 checkpoint 
signature was prognostic of distant metastasis-free survival. these results emphasize the value of expression profiling of 
primary melanomas for understanding melanoma biology and disease prognosis.
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in p53-dependent G
1
 checkpoint response to ionizing radiation 
(IR)-induced DNA damage.8 The common mutation of BRAF, 
which activates the mitogen-activated protein kinase (MAPK) 
signaling pathway, appears to be an early event in melanoma-
genesis, as it is seen as frequently in benign moles (nevi) as in 
primary melanomas.9 Malignant progression of BRAF-mutant 
lesions appears to require mutation or inactivation of PTEN.10 
Thus, melanoma cell lines can be recovered with mutation in 
BRAF, inactivation of p53 signaling and severely reduced expres-
sion of CDKN2A and PTEN mRNAs. Melanomagenesis involves 
many genetic and/or epigenetic alterations.
DNA damage checkpoints represent positions of control in 
the cell division cycle that delay or arrest cell division when 
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from the NHM control (FDR-adjusted p value = 0.08), while 
the SK-mel173 line displayed an average ratio of 0.28, which was 
significantly different from the NHM control (FDR-adjusted 
p value = 0.04). All melanoma lines with ratios > 0.3 were signifi-
cantly different from the NHM controls and thus defective for 
G
2
 checkpoint function. The melanoma lines displayed a broad 
range of responses to IR, with several lines responding to IR with 
severe G
2
 arrest (ratios < 0.05) and three lines with a highly atten-
uated response (ratios > 0.5).
As previously noted22 and now extended to this larger set of 
melanoma cell lines, there was significant melanoma subtype-
specific variation in G
2
 checkpoint function (Fig. 1B). Epithelial-
like melanoma lines with wild-type NRAS and BRAF alleles (here 
designated WT) displayed effective G
2
 arrest after IR, while lines 
with mutant NRAS or BRAF displayed significant attenuation of 
G
2
 checkpoint function (Fig. 1B).
Prior studies indicated that overexpression of RAS family 
oncogenes could attenuate G
2
 checkpoint function.23-25 To test 
whether mutation of BRAF was responsible for defective G
2
 
checkpoint function in melanoma cell lines, V5 epitope-tagged 
oncogenic B-Raf (V5V600E) under the control of a tetracycline-
responsive promoter was induced in a G
2
 checkpoint-effective 
melanoma line with wild-type BRAF and NRAS alleles. Addition 
of 1 μg/ml doxycycline (dox) to culture medium induced the 
expression of oncogenic B-Raf in RPMI8332 cells and accord-
ingly enhanced expression of P-MEK1/2 (Fig. 2A). Induction 
of oncogenic B-Raf was also associated with attenuation of 
the G
2
 arrest in response to treatment with IR (Fig. 2B). The 
attenuation of G
2
 checkpoint function upon induction of onco-
genic B-Raf was statistically significant (p = 0.02) but modest, 
with a 3-fold increase in the fractions of cells evading G
2
 arrest 
(Fig. 2C). A control experiment demonstrated that the addition 
of 1 μg/ml dox did not attenuate G
2
 checkpoint function in the 
parental line carrying the tetracycline transactivator but without 
oncogenic B-Raf (not shown). Thus, activation of MAPK signal-
ing likely contributed to the defective G
2
 checkpoint function 
seen in the BRAF-mutant melanoma cell lines, but other changes 
were probably needed to produce the severe attenuation seen in 
some of the lines.
A signature of G
2
 checkpoint function in melanoma cell 
lines. The melanoma cell lines were analyzed by DNA micro-
array to determine global gene expression during basal growth. 
Expression of mRNA species in individual melanoma cell lines 
(measured by Cy5) was determined relative to a universal ref-
erence standard (measured by Cy3) that was mixed with each 
sample. Cy5/Cy3 ratios were determined as a measure of gene 
expression using 44,000 probes on an Agilent microarray. A 
quantitative trait analysis (QTA) tool was implemented that 
determined the Spearman correlation coefficient for the rela-
tionship between G
2
 checkpoint function and gene expression. 
Table 1 shows that as the p value for this correlation was reduced 
incrementally from 0.007 to 0.002, the number of selected genes 
was reduced. At each increment the least absolute shrinkage and 
selection operator (LASSO) was applied in a leave-one-out cross 
validation (LOOCV) analysis to return a predicted value for G
2
 
checkpoint function. The R2 correlation between observed and 
component of the DNA damage response (DDR) that also 
includes activation of DNA repair at sites of damage, transcrip-
tional induction and repression and senescence or apoptotic cell 
death.12 Many studies have demonstrated that activated onco-
genes including mutant BRAF induce growth arrest in normal 
human cells through a process known as oncogene-induced 
senescence (OIS).13-19 OIS as induced by HRAS in normal human 
fibroblasts produced full activation of the DDR with expression 
of DDR markers such as γH2AX, phospho-ATM and phos-
pho-p53.14 Thus has arisen a model that activated oncogenes 
may induce precocious and aberrant DNA replication, leading 
to formation of DNA strand breaks and DNA damage check-
point-induced growth arrest.13,16 Attenuation of DNA damage 
checkpoint signaling overrides OIS, permitting outgrowth of 
oncogene-transformed clones.14,17,20 Consequently, it is impor-
tant to determine the functional capacity of DNA damage 
checkpoints in oncogene-driven malignancies and the biological 
consequences of checkpoint defects. This study has quantified 
the functional capacity of the ATM- and ATR-dependent DNA 
damage G
2
 checkpoint21 in normal human melanocytes (NHMs) 
and 35 melanoma cell lines. Defective G
2
 checkpoint function 
was detected in 37% of the melanoma cell lines, associated with 
significant alterations in gene expression. Some changes in gene 
expression reflected melanoma subtype-dependent variation, and 
others were correlated with G
2
 checkpoint function across the 
melanoma subtypes. A G
2
 checkpoint-predictive gene signature 
was found to have prognostic significance for development of dis-
tant metastasis in patients with primary melanoma, suggesting 




 checkpoint function in melanoma cell lines. 
NHM cultures displayed a significant inhibition of mitosis when 
analyzed 2 h after treatment with IR (1.5 Gy), indicative of G
2
 
arrest (Fig. 1A). The ratios of mitotic cells in IR-treated cultures 
in comparison to their sham-treated controls (IR/sham ratio) 
ranged from 2–20% among eight NHM cultures. The three 
new NHM cultures that were assayed in the current analysis 
responded to IR with the same degree of inhibition of mitosis as 
was seen previously in five other melanocyte cultures.22 NHM 
strains displayed an average 90% inhibition of mitosis 2 h after 




Melanoma cell lines displayed significant attenuation of DNA 
damage G
2
 checkpoint function in comparison to NHM, as evi-
denced by increased fractions of cells present in mitosis 2 h after 
irradiation (Fig. 1A). When analyzed as a class and compared 
against the normal melanocytes, the melanoma lines displayed 
a significant defect in checkpoint function (p = 0.02). When 
compared on an individual basis and corrected for multiple 
comparisons, 13 of 35 or 37% of the melanoma lines displayed 
a significant defect in G
2
 checkpoint function (Fig. 1A). The 
apparent cutoff for effective vs. defective G
2
 checkpoint function 
was 0.28–0.3. The WM2664 melanoma line displayed an aver-
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was 0.64 with a predictive accuracy of 88% (not shown). A total 
of 165 probes were present on both the QTA and Bayes lists (the 
QTA370, Bayes370 and overlapping 165 probe lists are given in 
the Supplemental Materials packet). These probes had a low p 
value (≤ 0.004) and low FDR (≤ 0.077). For this list of over-
lapping probes, the R2 correlation by LASSO was 0.64, and its 
predictive accuracy by LOOCV was 94% as shown in Figure 3A. 
Because the predictive accuracy of the 165 probe intersection list 
was greater than the QTA370 and Bayes370 lists, it was used for 
subsequent analyses.
Hierarchical clustering of the melanoma cell lines using the 165 
probe list produced two major clades with significant separation 
of checkpoint-effective and -defective lines (χ2 = 10.8, p = 0.02). 
predicted G
2
 checkpoint function was maximal (0.62) when 
the p value of the QTA was ≤ 0.004. At this p value cutoff, the 
predictive accuracy of LASSO was 85% i.e., 85% of melanoma 
lines were correctly predicted to have effective or defective G
2
 
checkpoint function (results not shown) with 370 probes being 
selected.
A second analysis used a Bayesian statistical tool to identify 
genes whose expression was correlated with G
2
 checkpoint func-
tion in the melanoma cell lines. The Bayesian tool returned a 
list of genes with variable false discovery rate (FDR), the lower 
the FDR the greater the correlation. The 370 probes with the 
lowest FDR (≤ 0.077) were collected and subjected to LASSO 
with LOOCV. The R2 correlation of the Bayes 370 probe list 
Figure 1. G2 checkpoint function in NHM and melanoma cell lines. Flow cytometry was used to quantify mitotic cells with expression of phospho-H3 
(ser10).22 G2 checkpoint function was scored as the ratio of the fractions of cells in mitosis 2 h after treatment with 1.5 Gy IR or a sham treatment  
(IR/sham ratio). the values shown represent individual determinations in NHM11, NHM16 and NHM18 cultures and mean values in melanoma cell lines 
(+ sd, n = 2–6). Black bars depict newly determined values while gray bars are from our previous report.22 All melanoma lines with values > 0.3 were 
determined to have defective G2 checkpoint function in comparison to NHMs (p < 0.05 after correction for multiple comparisons). the SK-Mel-173 line 
(*) was also defective. (B) G2 checkpoint function in melanoma cell lines belonging to three subtypes, “epithelial-like” with wild-type NRAS and BRAF 
(Wt), NRAS- mutant and BRAF-mutant. Results represent mean + sd (Wt, n = 5; NRAS, n = 8; BRAF, n = 22). (*) Denotes significantly different from Wt  
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category that was significantly over-represented in the 165 probe 
list, the lysosome. Eight lysosomal genes were on the list, STX3, 
USE1, FAM176A, ARSA, CTSA, DPP7, M6PR and ACP5. The 
commercial Ingenuity Pathways analytic tool did not identify 
a biological process or pathway as significantly associated with 
the G
2
 checkpoint signature list when correcting for multiple 
comparisons using the Benjamini-Hochberg method. However, 
manual curation of the 165 probe list revealed numerous genes 
whose expression could be expected to influence cell prolifera-
tion and/or G
2
 checkpoint function (Fig. 4 and Table 2). Many 
probes on the list act at steps in a KIT receptor tyrosine kinase-
initiated, MAPK-dependent signaling cascade leading to DNA 
replication and culminating in mitosis/cytokinesis. A total of 
31 probes on the 165 probe list encoded proteins that perform 
biological functions that are connected to this signaling cascade. 
Numerous biochemical activities were represented on the list, 
including ubiquitin ligation, de-ubiquitination, protein kinase, 
protein phosphatase, transcription factor, proteosome subunits 
and histone methylation and acetylation (Table 2).
The G
2
 checkpoint signature gene list included proteins that 
regulate cell proliferation and migration at numerous steps in 
the proliferation signaling cascade (Fig. 4 and Table 2). Several 
proteins regulate mitogen-activated protein kinase signal-
ing (RHOQ, YPEL4, DOCK10, MAP3K5), others regulate 
melanogenesis through the master transcription factor MITF 
(β-catenin, DAAM2, ICAM1), and a third cluster appears to 
influence signaling through the TGF-β receptor (TWSG1, 
MKL2). A substantial number of proteins on the list partici-
pate in DNA metabolism and mitotic cell division. WDHD1, 
KAT2B, MMS22L, ARTNL2 and HERC2 are implicated in 
various forms of DNA metabolism or damage response and 
MNAT1, SETDB2, CKS1B, PP4R1, FBXO5, FOXA1, WAPAL 
and SPG20 are associated with steps of mitosis (prophase, meta-
phase, anaphase, telophase) culminating in cytokinesis. Thus, 
the core machinery of the cell division cycle did not appear to 
be altered in melanoma cell lines in a way that was correlated 
with G
2
 checkpoint function, while many regulators of the core 
machinery were.
Notable probes on the G
2
 checkpoint signature list included 
CKS1B, WDHD1 and H2AFY2 (Fig. 5). CKS1B is a subunit of 
the cyclin B1/Cdk1 mitosis-promoting factor (MPF) kinase and 
mediates MPF interaction with the anaphase-promoting com-
plex/cyclosome (APC/C) that ubiquitinates cyclin B1 to trigger 
the metaphase-to-anaphase transition in mitotic cells. CKS1B 
mRNA was comparatively low in primary and hTERT-transduced 
The predictive accuracy of this binary hierarchical cluster analy-
sis was 77% (Fig. 3B).
Genes on the 165 probe list. Gene ontology analysis using 
Expression Analysis Systematic Explorer identified one biological 
Figure 2. Stimulation of MApK signaling by oncogenic B-Raf attenuates 
G2 checkpoint function in melanoma cells. (A) Western immunoblot 
showing induction of V5-V600e B-Raf and stimulation of MApK signaling 
(p-MeK1/2) in the melanoma line RpMI8332. Cells were incubated with 
1 μg/ml doxycycline (dox) for 48 h before cell harvest. (B) IR-induced 
G2 arrest. Flow cytometry was used to quantify mitotic cells 2 h after 
treatment with 1.5 Gy IR given at 48 h after adding dox. (C) Average IR/
sham ratios with and without induction of oncogenic B-Raf. Induction 
of oncogenic B-Raf for 24–48 h produced a modest but significant  
(p = 0.02, n = 5, Student’s t-test) attenuation of IR-induced G2 arrest.
Table 1. QtA and LASSo tools identify G2 checkpoint-correlated probes
Sig. levela 0.002 0.003 0.004 0.005 0.006
probe listb 205 290 370 434 515
LooCV- R-sqc 0.48 0.60 0.65 0.51 0.53
aSignificance threshold of the Spearman correlation test using QtA; 
bNumber of significant probes. the number of probes passing primary 
filtration was 23,354; cprediction of G2 checkpoint function using leave-
one-out cross-validation (LooCV). R-sq is the proportion of variation in 
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of H2AFY2 in NHM cultures and melanoma cell lines. In com-
parison to primary NHM cultures, H2AFY2 expression was 
suppressed in NHM lines that were transduced with hTERT 
to induce telomerase activity. Expression of H2AFY2 in NHM 
primary cultures and NHM-hTERT lines did not differ with 
supplementation of melanocyte growth medium with phorbol 
myristylate (PMA) or endothelin-1 (ET1). The NHM-hTERT 
lines displayed a very low level of expression of H2AFY2 simi-
lar to that seen in three of nine melanoma lines with NRAS 
mutations and 13 of 23 melanoma lines with BRAF mutations. 
In contrast, the WT melanoma lines uniformly displayed high 
expression of H2AFY2.
NHM and melanocytic nevi express low levels of telomerase 
and nodular melanoma, metastatic melanoma and melanoma 
cell lines express high levels of telomerase31,32 indicating that 
induction of telomerase is associated with malignant transfor-
mation of melanocytes. The repression of H2AFY2 expression 
in melanocytes that were transduced with hTERT to induce 
telomerase activity and immortality suggested that expression 
of H2AFY2 might be connected to the senescence pathway that 
recognizes deprotected telomeres that develop during cellular 
aging. Telomerase enzyme activity was quantified to test whether 
the elevated expression of H2AFY2 in WT melanoma cell lines 
melanocytes and high in melanoma cell lines, consistent with 
the enhanced proliferation of the melanoma cell lines (Fig. 5). 
Expression of CKS1B was also high in G
2
 checkpoint-effective 
melanoma cell lines and low in checkpoint-defective lines. All 
three melanoma subtypes displayed reduced expression with 
decreased G
2
 checkpoint function, but only in the BRAF-mutant 
subtype lines was the correlation significant (p = 0.02).
WDHD1, also known as AND1 and CTF4, has been shown 
to contribute to loading of DNA pol α at replicon origins 
through a direct interaction with a checkpoint mediator protein 
Tipin.26 Tipin is a component of the replication fork protection 
complex that mediates both the intra-S checkpoint response to 
UV-induced DNA damage27,28 and the G
2
 checkpoint response 
to IR-induced DNA damage.29 Low WDHD1 expression was 
associated with defective G
2
 checkpoint function (Fig. 5). The 
correlation of WDHD1 expression with G
2
 checkpoint function 
was significant for both the NRAS-mutant (p = 0.05) and BRAF-
mutant (p = 0.01) melanoma lines. WDHD1 expression was also 
higher in the melanoma cell lines than in the primary and telom-
erized melanocytes.
H2AFY2, also known as macro-H2A2, is a minor histone 
variant that is concentrated in senescence-associated heterochro-
matin.30 Expression of H2AFY2 was uniformly high in check-
point-effective WT melanoma cell lines, in which decreased G
2
 
checkpoint function was correlated with increased expression of 
H2AFY2 (Fig. 5, p = 0.02). The reduced expression of H2AFY2 
in NRAS- and BRAF-mutant melanoma cell lines was not cor-
related with reduced G
2
 checkpoint function (p > 0.05). Further 
inspection of the data revealed substantial variation in expression 
Figure 3. G2 checkpoint probe list predicts G2 checkpoint function. (A) 
the 165 probe list that was identified as the overlap between the QtA 
377 probe list with p ≤ 0.004 and the 377 probe Bayes list with FDR ≤ 
0.077 was subjected to LASSo with LooCV. LASSo returned an equation 
for prediction of G2 checkpoint function as: ∑i cixi + 0.399, where ci and 
xi are the coefficient and expression for the i-th transcript, respectively 
(Supplemental Materials packet). Values of G2 checkpoint function that 
were predicted by LASSo were plotted against the observed values. 
the cutoff value for effective vs. defective G2 checkpoint function was 
0.31. LASSo correctly classified G2 checkpoint function for 94% of the 
melanoma cell lines. the two misclassified lines were the checkpoint-
effective line SK-Mel-27 with an observed IR/Sham ratio of 0.18 and a 
predicted ratio of 0.41 and the checkpoint defective line SK-Mel-173 
with an observed ratio of 0.28 and a predicted ratio of 0.22. (B) Unsuper-
vised hierarchical cluster of 35 melanoma cell lines using the 165 probes 
that were correlated with G2 checkpoint function (p ≤ 0.004 and FDR ≤ 
0.077). Gene expression in melanoma cell lines was visualized using the 
method of eisen et al.,60 which organizes lines and transcripts according 
to similarity. transcripts that were expressed at greater levels than the 
group median are shown in red, and transcripts that were expressed at 
lesser levels than the group median are shown in green. the intensity 
of color is proportional to the separation from the median. the two 
major clades (branches) in the melanoma cell line dendogram largely 
represented checkpoint-defective (left clade) and checkpoint-effective 
(right clade) classes. there were eight lines that were misclassified for 
a correct classification rate of 77%. Melanoma lines with mutations in 
BRAF and NRAS were represented in both classes. Melanoma lines with 
wild-type BRAF and NRAS were restricted to the checkpoint-effective 
class. Chi-square analysis indicated significant separation of checkpoint-
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were in the G
2
 checkpoint gene signature 
returned a significant separation of out-
come in the melanoma patient samples 
(p = 0.018). Thus, in an independent 
melanoma data set, genes whose expres-
sion was correlated with DNA damage 
G
2
 checkpoint function were prognostic 
of melanoma outcome.
A similar analysis of DNA damage G
1
 
checkpoint function in melanoma cell 
lines generated a different signature of 
gene expression that also was prognostic 





 checkpoint signatures contained no 
overlapping probes. To test whether a 
combination of the two prognostic tests 
performed better than either individual 
test, SRP was done to identify patients 
who were classified as high risk in both 
signatures or low risk in both signatures. 
The separation of metastasis incidence 
for the high/high and low/low groups 
was greater that than obtained using 
the G
2
 signature alone but less than that 
obtained using the G
1
 signature alone. 
The χ2 values for the individual tests were 





, respectively, and the χ2 value 






signatures did not improve prognostic 
identification of patients with high risk to 
develop a distant metastasis, in compari-
son to the G
1
 signature used alone.
Discussion
Melanoma cell lines displayed substantial variation in DNA 
damage G
2
 checkpoint function with 37% being classified as 
defective in comparison to NHM cultures. Expression of onco-
genic B-Raf appeared to attenuate G
2
 checkpoint function only 
modestly, implying that other genetic or epigenetic alterations are 
required to produce the severely defective G
2
 checkpoint func-
tion seen in some melanoma cell lines. Bioinformatic analyses of 
global gene expression identified 165 probes that were correlated 
with G
2
 checkpoint function with low p values and low FDR. 
Gene products that are translated from these mRNAs were not 
core components of the cell cycle but rather mediators. Probes on 
the G
2
 checkpoint signature list were prognostic for melanoma 
progression in an independent data set.
Defects in G
2
 checkpoint function were restricted to mela-
noma cell lines with mutant BRAF and NRAS oncogenes. Many 
reports have associated defects in G
2
 checkpoint function with 
activation of the MAPK signaling pathway,23-25,35 but few studies 
have focused on the effects of oncogenic B-Raf. Expression of 
oncogenic B-Raf at levels sufficient to activate MEK1/2 produced 
affected expression of telomerase. Melanoma lines with high 
expression of H2AFY2 (PMWK, RPMI8322) displayed high lev-
els of telomerase similar to those seen in melanoma lines with 
intermediate or low expression of H2AFY2 (Fig. S1). Thus, it 
appeared that expression of H2AFY2 was not correlated with the 
induction of telomerase activity in melanoma.
Prognostic significance of G
2
 checkpoint signature list. To 
test the biological significance of the G
2
 checkpoint signature list, 
an independent melanoma microarray database was analyzed. 
Winnepenninckx et al. quantified gene expression in 58 primary 
melanomas that did or did not develop distant metastases within 
4 y of primary diagnosis.33 The primary Agilent microarray data 
were downloaded from an open source and loaded into BRB 
array tools to generate Cy5/Cy3 ratios as indices of gene expres-
sion; a total of 6307 probes passed filtration and were available 
for analysis.34 Of the 165 probes on the G
2
 checkpoint signature 
list, 32 were present in the filtered melanoma data set. These 32 
probes were analyzed with a survival risk prediction (SRP) tool to 
generate two groups, one with low risk of development of distant 
metastasis, the other with high risk (Fig. 6). The 32 probes that 
Figure 4. G2 checkpoint-correlated genes encode mediators of a receptor tyrosine kinase signaling 
cascade initiating DNA replication and culminating in mitotic cell division. KIt activates the MApK 
signaling cascade to initiate DNA replication. DNA replication stress produces DNA double-strand 
breaks, which activate the sensor checkpoint kinases AtM and AtR and the transducer checkpoint 
kinases Chk1 and Chk2. Inhibition of Cdc25B blocks the activation of mitosis-promoting factor (cy-
clin B1/Cdk1) to enforce the G2 checkpoint. once activated in the nucleus, mitosis-promoting factor 
activates the anaphase-promoting complex to complete chromatid segregation (karyokinesis) and 
cell division (cytokinesis). Additional signaling from MItF and tGFβ impinges on the core pathway. 
Checkpoint-correlated gene products are enclosed in ovals near the proteins or processes that they 
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were identified with severe reductions in PTEN mRNA levels. 
However, PTEN mRNA expression was not correlated with G
2
 
checkpoint function (not shown). The WM35 melanoma line 
with mutant BRAF and a severe defect in G
2
 checkpoint function 
expressed PTEN mRNA at levels seen in NHM and telomerase-
expressing NHM. Moreover, the checkpoint-effective PMWK 
line displayed very low expression of PTEN mRNA associated 
with homozygous deletion of the PTEN gene locus (results not 
shown). Reduced expression of PTEN mRNA did not account 
for the reduced G
2
 checkpoint function in BRAF-mutant mela-
noma cell lines. Activation of AKT was recognized in many of 
the melanoma cell lines studied here and the “epithelial-like” 
melanoma lines with wild-type NRAS and BRAF expressed lower 
levels of phospho-AKT than the lines with oncogene mutations.39 
Mutational inactivation of PTEN and/or mutational activation 
of AKT (without alteration in mRNA levels) might contribute to 
reduced G
2
 checkpoint function in BRAF-mutant melanoma cell 
a modest but significant attenuation of G
2
 checkpoint function 
in the RPMI8322 melanoma line. As some melanoma cell lines 
displayed a severe attenuation of the G
2
 checkpoint, the results 
suggest that other melanoma-associated phenotypic alterations 
also influence the G
2
 checkpoint response to IR-induced DNA 
damage.
Two proteins in the melanomagenesis pathway, PTEN and 
AKT, have been reported to interact with or influence the 
checkpoint transducer kinase CHK1.36,37 Inactivation of PTEN 
appeared to reduce CHK1 kinase activity within the nucleus by 
cytoplasmic sequestration.37 AKT was shown to phosphorylate 
CHK1 on ser180 to promote its cytoplasmic sequestration.37 
Reduced activity of PTEN or activation of AKT therefore might 
attenuate the G
2
 checkpoint response to IR-induced DNA dam-
age by deregulating CHK1. BRAF mutations appear to cooperate 
with inactivation of PTEN in melanomagenesis.4,10,38 In the cur-
rent series, many of the melanoma lines with mutations in BRAF 
Table 2. G2 checkpoint-correlated genes encode products that mediate regulation of cell division and the G2-M transition
Gene name Biochemical activity Biological function References
DLG3 Guanylate kinase polarity, proliferation 61
PTPRM protein tyrosine phosphatase Migration, proliferation 62
MAP3K5 MApK kinase kinase p38 kinase activation 40
RHOQ Gtp binding Motility, attachment 63
YPEL4 Interacts with Vault proteins Regulate MApK pathway 64
DOCK10 Rho guanine exchange factor migration 65
DAAM2 Stabilize Dvl3/Axin2 binding Wnt signaling pathway 66
β-catenin transcription factor Wnt signaling pathway 38
ICAM1 Surface glycoprotein Adhesion, metastasis 67
TWSG1 BMp antagonist SMAD repression 68
MKL2 transcription factor Response to serum 69
HSF4 transcription factor Regulate senescence 70
WDHD1 Initiation of DNA replication Load DNA pol α 26
KAT2B Histone acetyltransferase transcriptional coactivation; regulated by WDHD1 71 and 72
MMS22L Ubiquitin ligase Restart collapsed forks 73
ARNTL2 transcription factor Circadian rhythm 74
HERC2 Ubiquitin ligase DNA repair, replication and checkpoint function 75
ANKRD28 phosphatase subunit Inactivate AuroraA 76
CTDSPL2 phosphatase Dephosphorylate RNA polII 77
MNAT1 Subunit of CAK CDK activation, transcription, DNA repair 50
PP4R1 phosphatase subunit Checkpoint recovery 78
SETDB2 Histone methylase enhance prophase to anaphase transition 79
SPG20 Microtubule interacting enhance cytokinesis 80
CKS1B CDK1 regulator Direct cyclinB1/Cdk1 to ApC/C, p27 degradation 81 and 82
FOXA1 transcription factor Stimulate ubiquitylation of cyclin B1 83
FBXO5 Ubiquitin ligase Inhibit ApC 84
WAPAL Cohesin interacting protein Sister chromatid resolution 85
H2AFY2 Chromatin condensation Senescence-associated heterochromatin, melanoma suppres-
sion
52
PSMB6 Y Subunit of proteosome Ubiqutin-mediated proteolysis 86
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found in 9% of melanoma cell lines.40 MAP3K5 mRNA was 
negatively correlated with G
2
 checkpoint function; thus, reduced 
expression of MAP3K5 mRNA was associated with increased 
fractions of cells evading IR-induced G
2
 arrest.
lines. A parallel branch of the MAPK pathway leading to acti-
vation of ERK1/2, p38SAPK and JNK includes MAP3K5 and 
MAP3K9. Inactivating base-substitution mutations in MAP3K5, 
a member of the 165 probe G
2
 checkpoint signature list, were 
Figure 5. Genes may regulate G2 checkpoint function in a melanoma subtype-dependent and -independent manner. NHMs and NHM lines that were 
transduced with hTERT are depicted in black. Wt melanoma lines are depicted in blue, NRAS-mutant lines in red and BRAF-mutant lines in purple. 
Gene expression is depicted as the ratio of mRNA expression in experimental samples (Cy5) divided by expression in a pool of cancer cell lines (Cy3, 
Stratagene universal reference mRNA). CKS1B and WHDH1 generally were expressed at higher levels in melanoma cell lines than in NHMs. Among 
melanoma lines, all three subtypes displayed a negative correlation between CKS1B and WDHD1 expression and G2 checkpoint function. H2AFY2 was 
expressed at low levels in NHMs expressing telomerase and in some NRAS- and BRAF-mutant melanoma lines. expression of H2AFY2 was uniformly 
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immortality in melanoma. However, no correlation between 
H2AFY2 and telomerase enzyme activity was observed in the 
melanoma cell lines, and lines with high expression of H2AFY2 
expressed telomerase activity at the same levels as lines with 
low expression of H2AFY2. The biological significance of high 
Bioinformatic analysis of the G
2
 checkpoint signature list 
identified the lysosome as a potential modifier of checkpoint 
function. The lysosome is a key organelle in the process of 
autophagy that degrades intracellular proteins by a non-pro-
teosomal mechanism.41 Autophagy has been linked to activa-
tion of cytoplasmic ATM,42 a key transducer kinase in the G
2
 
checkpoint immediately upstream of CHK1.12,43,44 Autophagy 
is also regulated by protein acetylation and deacetylation,45,46 
and recent studies demonstrate the requirement of protein 
acetylation and deacetylation in the response to DNA double-
strand breaks.47 The presence of the histone acetyltransferase 
KAT2B on the G
2
 checkpoint gene list provides a possible 
connection to lysosomes and autophagy.47,48
The list of checkpoint-correlated probes contained many 
genes that are connected to regulation of mitosis, including 
CKS1B, WHDH1 and MNAT1. A recent study has associ-
ated alterations in CKS family proteins with override of the 
replication checkpoint that blocks the initiation of mitosis in 
cells with incomplete DNA replication.49 The protein prod-
uct of WDHD1, AND1, is known to interact with Tipin, an 
established mediator of G
2
 checkpoint function.29 MNAT1 is 
a subunit of CAK, the CDK-activating kinase that phosphor-
ylates CDK1 on thr161.50 It is conceivable that a variety of 
combinations of alterations in gene expression are manifested 
as a functional defect in the ability to respond to IR-induced 
DNA damage and arrest in G
2
.
H2AFY2 appeared to be on the G
2
 checkpoint signature 
list because of its high expression in the “epithelial-like” mel-
anoma lines and reduced expression in NRAS- and BRAF-
mutant lines. Among the BRAF-mutant lines, expression of 
H2AFY2 was not correlated with G
2
 checkpoint function. 
Macro-H2A.2, the protein product of the gene locus, has 
been linked to cellular aging being induced in senescent 
cells.51 Macro-H2A proteins appear to concentrate in senes-
cence-associated heterochromatin, suggesting that macro-
H2A may help to organize a repressive chromatin structure 
that enforces senescence. Macro-H2A was shown to repress 
CDK8 in a melanoma cell line as a potential mechanism 
of tumor suppression.52 In the current data series, there was 
no correlation between H2AFY2 and CDK8 mRNA expres-
sion among the 35 melanoma cell lines (data not shown). The 
repression of H2AFY2 expression in melanocytes that were 
transduced with hTERT to induce telomerase activity and 
immortality suggested that expression of H2AFY2 might be 
connected to the mechanisms of regulation of telomerase and 
Figure 6. the G2 checkpoint signature list is prognostic for melano-
ma progression. primary melanomas were analyzed for global gene 
expression using the Agilent microarray platform. A 6307 probe 
set was downloaded from an open source and analyzed for probes 
that were prognostic for development of distant metastases within 
four years of resection of the primary tumor.8,33 the 165 probe set 
that was correlated with G2 checkpoint function was used with 
survival risk prediction to generate two patient groups, one with 
low probability of distant metastasis, one with high probability. the 
separation of the two groups in the Kaplan-Meier survival plot was 
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doxycycline (dox) to culture medium activated the tetracycline 
transactivator and induced expression of V5-tagged, oncogenic 
B-Raf (V5V600E). The parental RPMI8322 melanoma line was 
shown to display a severely defective G
1
 checkpoint response to 
ionizing radiation, demonstrating functional inactivation of p53 
signaling.8 Expression of V5V600E was monitored by immunob-
lot analysis using antibodies against V5 (Sigma), B-Raf (Cell 
Signaling) and phospho-MEK1/2 (Cell Signaling). Cells were 
assayed for G
2




 checkpoint function was compared between individual 
melanoma cell lines and a group of eight NHM strains, based on 
a linear mixed effects model57 to account for the potential corre-
lation of multiple measurements (median of 3 with interquartile 
range of 2–4) per cell line. A one-sided t-test used the predicted 
empirical Bayesian estimate of each cell line from the output of 
the linear mixed effects model to identify melanoma cell lines 
with significantly reduced IR-induced mitotic inhibition in com-
parison to the set of NHMs. P values were adjusted for multiple 
comparisons using the method of Benjamini and Hochberg.58
Signature of G
2
 checkpoint function. Analysis of gene expres-
sion using cDNA microarrays was done as previously described.8,22 
mRNA expression in NHM and melanoma cell lines (Cy5 dye) 
was expressed relative to a universal human mRNA standard 
(Cy3 dye). The log
2
 ratio of Cy5 to Cy3 intensities was computed 
for each probe.
Analysis of microarray data was done using BRB array tools 
software.59 Quantitative trait analysis (QTA) used the Spearman 
correlation coefficient to identify genes whose expression was cor-
related with G
2
 checkpoint function in melanoma cell lines. A 
Bayesian method for selection of significant genes was applied as 
previously described22 to identify G
2
 checkpoint-correlated genes 
with low false-discovery rate (FDR < 0.077). The least absolute 
shrinkage and selection operator (LASSO) was used with leave-
one-out cross validation (LOOCV) to predict G
2
 checkpoint 
function from gene expression signatures. Hierarchical clustering 
was also used to predict G
2
 checkpoint-effective and -defective 
melanoma cell lines.
Gene ontology analysis was done using DAVID 6.7 
(http://david.abcc.ncifcrf.gov/). The Ingenuity Pathways tool 
was used to search for biological functions and pathways that 
are associated with genes in the G
2
 checkpoint signature. The 
survival risk prediction BRB array tool was used to determine 
whether a G
2
 checkpoint gene signature predicted development 
of distant metastasis in an independent data set33 as was done 
previously using a G
1
 checkpoint gene signature.8
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expression of H2AFY2 in WT melanoma cell lines remains to 
be determined.
Given that DNA damage checkpoints slow cell cycling and 
stabilize the genome,53-55 it is axiomatic that defects in checkpoint 
function enhance neoplastic growth and genomic instability, 
thereby fueling malignant progression. This facet of cancer biol-
ogy may be reflected in the result that signatures of gene expres-




 checkpoint function were 
also prognostic for a measure of melanoma disease progression, 





point signatures did not contain any overlapping transcripts, and 




 checkpoint function 





 signatures did not improve prognosis suggests 




 checkpoints use different path-
ways to enforce a common barrier to melanomagenesis.
Materials and Methods
Molecular biology and viral transduction. A V5-tagged onco-
genic BRAF (V600E) insert was synthesized and cloned into 
the pRetro-X-Tight-Hyg (Clonetech) vector by Blue Heron 
Biotechnology. The V5-BRAF insert was confirmed by sequence-
ing (data not shown). Virus was packaged and cells infected using 
standard methods as described previously.56 The RPMI8322 cell 
line that is wild-type for NRAS and BRAF was first infected with 
the Retro-X-TetON-Advanced (Clonetech) virus to express the 
TetON transactivator. Following 1 wk of selection in 500 μg/ml 
G418 (Life Technologies), the cells were infected with the 
V5-BRAF-expressing virus. These cells were subsequently selected 
in 100 μg/ml Hygromycin B (Roche) for 1 wk prior to use.
Cell culture and assay of G
2
 checkpoint function. Normal 
human melanocytes (NHMs) and melanoma cell lines were 
grown and assayed for G
2
 checkpoint function as previously 
described.22 Cells were routinely assayed for mycoplasma con-
tamination using commercial kits (Geneprobe, Gene-Probe and 
PlasmoTest™, Invivogen). Contaminated cultures were cleansed 
with ciprofloxacin and/or a commercial antibiotic (Plasmocin, 
Invivogen). Results are reported only for mycoplasma-negative 
cell cultures. NHM cultures were grown in growth medium 
supplemented with phorbol myristylate (PMA) as previously 
described22 or when indicated PMA was replaced with endothe-
lin-1 (ET1) at 100 ng/ml. To induce expression of telomerase and 
generate immortal lines NHM were transduced with hTERT by 
retroviral infection and selection with puromycin (50 μg/ml) as 
previously described56 then grown with PMA or ET1.
G
2
 checkpoint function was quantified by flow cytomet-
ric determination of the fraction of cells that were positive for 
expression of phospho-ser10 histone H3 as measured 2 h after 
irradiation with 1.5 Gy IR using a RS2000 Biological Irradiator 
(Rad-Source). The fraction of cells in mitosis in IR-treated cul-
tures was expressed as a percentage of the same fraction scored in 
sham-treated controls.
The RPMI8322 cell line and its derivative were grown in high-
glucose DMEM (Life Technologies or Cellgro) supplemented 
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